Treatment Patterns, Healthcare Resource Utilization, and Costs in Medicare Patients with Diffuse Large B-cell Lymphoma: a Retrospective Claims Analysis (2015-2020)

Monika P. Jun,Alex Mutebi,Anindit Chhibber,Chenxue Liang,Allison Keshishian,Anthony Wang,Fernando Rivas Navarro,Anupama Kalsekar, Jing He,Tongsheng Wang

Journal of Medical Economics（2024）

Cited 0|Views4

Key words

Large B cell lymphoma,chimeric antigen receptor therapy,cost of illness,economic burden,event-free survival,hospitalization,non-Hodgkin lymphoma,standard of care,treatment patterns,healthcare resource utilization,I10,I1,I19

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined